Prospective randomized comparison of intravesical BCG therapy with standard dose versus low doses in superficial bladder cancer

@article{Yalcinkaya1998ProspectiveRC,
  title={Prospective randomized comparison of intravesical BCG therapy with standard dose versus low doses in superficial bladder cancer},
  author={Fatih Rustu Yalcinkaya and L. Kamiş and O. {\"O}zteke and B{\"u}lent G{\"u}nl{\"u}soy and Orhan Gazi Yiğitbaşi and Serhat {\"U}nal},
  journal={International Urology and Nephrology},
  year={1998},
  volume={30},
  pages={41-44}
}
In this study, we evaluated low dose intravesical bacillus Calmette-Guerin (BCG) therapy following transurethral resection (TUR) in 80 patients with superficial bladder cancer. The patients were divided into two groups. Of the Connaught BCG strain 81 mg was given to 40 patients in Group 1 and 54 mg to the remainder of 40 patients in Group 2. BCG was introduced once a week for 6 weeks. Tumour recurrence was seen in 6 patients in Group 1 and in 10 patients in Group 2. Recurrence rates per month… CONTINUE READING
7 Citations
16 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-7 of 7 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 16 references

Intravesical therapy

  • D. L. Lamm, J. G. Griffin
  • Semin. Urol., 10, 39
  • 1992
1 Excerpt

A low dose BCG regimen in superficial bladder cancer therapy: Is it effective? d

  • F. Pagano, P. Bessi
  • Urol., 146, 32
  • 1991
1 Excerpt

BCG and interleukin-2 Ibr treatment of superficial bladder cancer

  • A.T.K. Cockett, R. S. Davis, L. R. Cos, Wheeless, L. L.
  • J. Urol.,
  • 1991
1 Excerpt

TUR and intravesical therapy of superficial bladder tumor

  • W. Harry
  • Urol. Oncol., 18, 525
  • 1991
1 Excerpt

A randomized prospective comparison of oral versus intracavitary BCG tbr superficial bladder ttunor

  • D. L. Lamm
  • J. Urol., 144, 65
  • 1990
2 Excerpts

Handling and use of intravesical BCG for the mmlagement of stage Ta, T1, ca in situ and transitional bladder cancer

  • S. A. Brosman, Lamm, L. I.
  • J. Urol., 144, 313
  • 1990
1 Excerpt

Effectiveness of a low dose BCG therapy in superficial cancer

  • F. Pagano
  • J. Urol., 141, 334
  • 1989
1 Excerpt

Advances in the treatment of urothelial tumors

  • C. N. Stenberg, H. I. Scher
  • Urol. Clin. 1~: Am., 14, 373
  • 1987
2 Excerpts

An overview of intravesical therapy for superficial bladder tumors

  • H. W. Herr
  • J. UroL, 16, 1363
  • 1987

Similar Papers

Loading similar papers…